Aims to enhance Frontage's global lab service capabilities and strengthen its presence in China and the Asia-Pac region.
XyloCor Therapeutics Inc. has appointed John Tucker as President and Chief Executive Officer (CEO), effective immediately.
Novartis has unveiled plans to establish a new 46,000-square-foot radioligand therapy (RLT) manufacturing site in Denton, ...
Therna Biosciences has joined forces with Charles River to advance single-patient RNA medicines for individuals with severe, ...
Upperton has submitted an application to the UK’s Medicines and Healthcare Products Regulatory Agency for approval of its new ...
Arcutis Biotherapeutics is promoting Mas Matsuda, senior vice president and general counsel, to executive VP and chief legal ...
SmartSkin Technologies has introduced SmartSkin Seal Assurance, a solution designed to give pharmaceutical manufacturers real ...
Invivyd, which focuses on protection against viral infectious diseases, is naming Michael Mina, MD, PhD, chief medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results